Reviewed : All Cyclopamine Positive Aspects As well as Disadvantages

Every effort was taken to minimize discomfort to the animals. Stem cells derived from the adult human olfactory mucosa are multipotent [20] and exhibit extensive proliferation in vitro (Fig. 1A). Consistent with recent findings [24, 29], cells of the stem cell line used in this study were found to express mesenchymal stem cell markers, CD44, Stro-1, and vimentin (Fig. 1B-1D; [30, 31]) and to possess the capacity to differentiate into mesodermal cell types (Fig. 1E, 1F). Undifferentiated olfactory stem cells also expressed immunoreactivity to the neuronal marker ��-tubulin III (Fig. 1A), a characteristic of certain types of mesenchymal stem cells [32�C34]. Together, these results are consistent with the recent classification of human olfactory stem cells as a subtype of mesenchymal stem cell [24] rather than previous classifications http://www.selleckchem.com/products/BI-2536.html as a subtype of neural stem cell [22, 23]. To examine the effects of olfactory stem cell transplantation on early-onset hearing http://www.selleck.cn/products/gsk126.html loss, A/J mice at P28�CP37 (the age at which elevations in hearing thresholds are first apparent) were separated into two cohorts: Transplant and Sham. Comparable levels of hearing loss were present in the animals assigned to the two cohorts (p > .05; Fig. 2B), as assessed by ABR (hearing) thresholds to click and pure tone (16 kHz) stimuli. ABR threshold levels were comparable with those reported previously [9]. All mice were immunosuppressed before surgery. Mice within the Transplant cohort received a unilateral cochlear injection of olfactory stem cells, whereas those of the Sham cohort received http://www.selleckchem.com/products/Cyclopamine.html a unilateral cochlear injection of the vehicle solution (PBS). Hearing threshold levels for the injected ears of the two cohorts were examined 4 weeks following transplantation/sham surgery. Two separate comparisons were completed to assess the functional effects of olfactory stem cell transplantation. In the first comparison, hearing threshold levels in the injected ears of the Transplant and Sham cohorts at 4 weeks after surgery were compared (Fig. 3A, 3B; Tables 1, 2). This analysis revealed that for both click and 16 kHz pure tone stimuli, ABR threshold levels were significantly lower in mice of the Transplant cohort (click: 77.9 �� 2.9 dB SPL; 16 kHz pure tone: 76.9 �� 3.7 dB SPL) than those of Sham cohort (click: 85.4 �� 1.6 dB SPL, p